Search research articles
Contact Us
Filters
Showing results (21-30 of 158) with videos related to
Page
of 16
Sort By:
The New England Journal of Medicine
|
March 24, 2006
Treatment for rheumatic disorders
Elizabeth A Tindall, David A Fox
Critical Reviews in Immunology
|
October 9, 2013
Regulation of Th17 maturation by interleukin 4
Laura A Cooney, David A Fox
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 23, 2013
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis
Heather S Gladue, David A Fox
Current Opinion in Rheumatology
|
January 22, 2014
T cell subsets and their role in the pathogenesis of rheumatic disease
Alison M Gizinski, David A Fox
Modern Rheumatology
|
January 12, 2013
The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts
Hiroshi Kato, Judith Endres, David A Fox
Rheumatology (Oxford, England)
|
August 24, 2016
Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases
Sabrina Fechtner, David A Fox, Salahuddin Ahmed
Best Practice & Research. Clinical Rheumatology
|
August 25, 2010
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets
Alison M Gizinski, David A Fox, Sujata Sarkar
Journal of Immunology (Baltimore, Md. : 1950)
|
December 19, 2019
CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders
Chenyang Lu, Mohammad A Amin, David A Fox
Current Opinion in Rheumatology
|
January 2, 2024
New molecular targets in the treatment of rheumatoid arthritis
Beth I Wallace, Laura Cooney, David A Fox
Seminars in Immunopathology
|
May 13, 2017
Synovial cellular and molecular markers in rheumatoid arthritis
M Asif Amin, David A Fox, Jeffrey H Ruth
Page
of 16
Search research articles
Search
Showing results (21-30 of 158) with videos related to
Sort By:
Page
of 16
The New England Journal of Medicine
|
March 24, 2006
Treatment for rheumatic disorders
Elizabeth A Tindall, David A Fox
Critical Reviews in Immunology
|
October 9, 2013
Regulation of Th17 maturation by interleukin 4
Laura A Cooney, David A Fox
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
November 23, 2013
Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis
Heather S Gladue, David A Fox
Current Opinion in Rheumatology
|
January 22, 2014
T cell subsets and their role in the pathogenesis of rheumatic disease
Alison M Gizinski, David A Fox
Modern Rheumatology
|
January 12, 2013
The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts
Hiroshi Kato, Judith Endres, David A Fox
Rheumatology (Oxford, England)
|
August 24, 2016
Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases
Sabrina Fechtner, David A Fox, Salahuddin Ahmed
Best Practice & Research. Clinical Rheumatology
|
August 25, 2010
Pharmacotherapy: concepts of pathogenesis and emerging treatments. Co-stimulation and T cells as therapeutic targets
Alison M Gizinski, David A Fox, Sujata Sarkar
Journal of Immunology (Baltimore, Md. : 1950)
|
December 19, 2019
CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders
Chenyang Lu, Mohammad A Amin, David A Fox
Current Opinion in Rheumatology
|
January 2, 2024
New molecular targets in the treatment of rheumatoid arthritis
Beth I Wallace, Laura Cooney, David A Fox
Seminars in Immunopathology
|
May 13, 2017
Synovial cellular and molecular markers in rheumatoid arthritis
M Asif Amin, David A Fox, Jeffrey H Ruth
Page
of 16